UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.806-812

2016

Volltextzugriff (PDF)

Measuring FVIII activity of glycopegylated recombinant factor VIII, N8‐GP, with commercially available one‐stage clotting and chromogenic assay kits: a two‐centre study

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.458-465

2017

Volltextzugriff (PDF)

Accurate measurement of extended half‐life and unmodified factor VIII low levels with one‐stage FVIII assays is dependent on the matrix of calibration curves

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-01, Vol.25 (1), p.e19-e26

2019

Volltextzugriff (PDF)

Measurement of B‐domain‐deleted ReFacto AF activity with a product‐specific standard is affected by choice of reagent and patient‐specific factors

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.675-682

2018

Volltextzugriff (PDF)

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1549-1555

2011

Volltextzugriff (PDF)

A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-11, Vol.22 (6), p.957-965

2016

Volltextzugriff (PDF)

Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-05, Vol.19 (3), p.e133-e138

2013

Volltextzugriff (PDF)

Recombinant to modified factor VIII and factor IX - chromogenic and one-stage assays issues

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (S5), p.72-77

2016

Volltextzugriff (PDF)

In vivo recovery with products of very high purity - assay discrepancies

Haemophilia : the official journal of the World Federation of Hemophilia, 1998-07, Vol.4 (4), p.641-645

1998

Volltextzugriff (PDF)

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-09, Vol.14 (5), p.1049-1054

2008

Volltextzugriff (PDF)

Factor VIII assay mimicking in vivo coagulation conditions

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-03, Vol.20 (2), p.e164-e170

2014

Volltextzugriff (PDF)

The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX

International journal of laboratory hematology, 2020-12, Vol.42 (6), p.810-818

2020

Volltextzugriff (PDF)

Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A

International journal of laboratory hematology, 2009-04, Vol.31 (2), p.180-188

2009

Volltextzugriff (PDF)

Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys)

Blood transfusion = Trasfusione del sangue, 2015-10, Vol.13 (4), p.622-630

2015

Volltextzugriff (PDF)

Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-11, Vol.12 (s4), p.23-29

BARROWCLIFFE, T. W.

2006

Volltextzugriff (PDF)

Accuracy of FVIII:C assay by one‐stage method can be improved using hemophilic plasma as diluent

Journal of thrombosis and haemostasis, 2006-04, Vol.4 (4), p.828-833

2006

Volltextzugriff (PDF)

Haemophilia A and von Willebrand's disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (s5), p.79-84

2010

Volltextzugriff (PDF)

A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran

Blood transfusion = Trasfusione del sangue, 2011-10, Vol.9 (4), p.394-399

2011

Volltextzugriff (PDF)

Laboratory and Quality Control of Assays

Textbook of Hemophilia, 2014, p.309-317

2014

Volltextzugriff (PDF)

Assay of Factor VIII and Other Clotting Factors

Quality in Laboratory Hemostasis and Thrombosis, 2013, p.105-114

2013

Volltextzugriff (PDF)

Treatment of Von Willebrand Disease: Desmopressin

Textbook of Hemophilia, 2010, p.316-319

2010

Volltextzugriff (PDF)

Laboratory Assays in Hemophilia

Textbook of Hemophilia, 2010, p.247-253

2010

Volltextzugriff (PDF)

Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL

Journal of thrombosis and haemostasis, 2024-10, Vol.22 (10), p.2745-2751

2024

Volltextzugriff (PDF)

Variability in combinations of APTT reagent and substrate plasma for a one‐stage clotting assay to measure factor VIII products

International journal of laboratory hematology, 2024-08, Vol.46 (4), p.705-713

2024

Volltextzugriff (PDF)

Clinical utility of sample preheat treatment in a modified Nijmegen‐Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single‐centre four‐year experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.e300-e307

2020

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(81)
Buchkapitel
(9)

Sprache

Englisch
(89)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII

Measuring FVIII activity of glycopegylated recombinant factor VIII, N8‐GP, with commercially available one‐stage clotting and chromogenic assay kits: a two‐centre study

Accurate measurement of extended half‐life and unmodified factor VIII low levels with one‐stage FVIII assays is dependent on the matrix of calibration curves

Measurement of B‐domain‐deleted ReFacto AF activity with a product‐specific standard is affected by choice of reagent and patient‐specific factors

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A

A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE

Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory

Recombinant to modified factor VIII and factor IX - chromogenic and one-stage assays issues

In vivo recovery with products of very high purity - assay discrepancies

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

Factor VIII assay mimicking in vivo coagulation conditions

The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX

Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A

Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys)

Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A

Accuracy of FVIII:C assay by one‐stage method can be improved using hemophilic plasma as diluent

Haemophilia A and von Willebrand's disease

A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran

Laboratory and Quality Control of Assays

Assay of Factor VIII and Other Clotting Factors

Treatment of Von Willebrand Disease: Desmopressin

Laboratory Assays in Hemophilia

Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL

Variability in combinations of APTT reagent and substrate plasma for a one‐stage clotting assay to measure factor VIII products

Clinical utility of sample preheat treatment in a modified Nijmegen‐Bethesda assay (mNBA) for inhibitor monitoring in congenital and acquired haemophilia A: A single‐centre four‐year experience

Suchergebnisse filtern